NEW YORK (GenomeWeb News) — Keygene has licensed some of its genomic technology to a research group in Ghent University in Belgium, Keygene said Tuesday.
The five-year, non-exclusive agreement allows the Belgian Coordinated Collection of Microorganisms at the Laboratory for Microbiology at Ghent University, or BCCM/LMG, to use Keygene’s AFLP technology to “extend its genetic database” and “serve its customers with AFLP typing of bacterial stains.”
AFLP is a DNA marker technology for genome analysis, transcript profiling, and genetic analysis. BCCM/LMG manages bacterial strains for the Belgian BCCM Consortium.
Ghent University used the technology in the early 1990s to build its bacterial database, said BCCM/LMG director Paul de Vos.
Financial terms of the agreement were not released.